Malaysia

Denmark-based pharmaceutical company Lundbeck has expanded its agreement with Israel-based partner Teva. The Danish drugmaker will sell Parkinson's disease drug Azilect (rasagline)... 2010-02-26

Malaysian drugmaker Pharmaniaga 'remains focused on strategies' despite releasing disappointing 2009 financial results. Sales and profit before tax both decreased compared with the... 2010-02-22

To boost sales and profit, Malaysian drugmaker CCM Duopharma is looking to export high-value products to neighbouring countries. Given the relatively limited size and growth of the... 2010-02-19

Malaysia's Drug Control Authority (DCA) has reminded pharmaceutical companies to inform it of changes to their production processes. Failure to do so will result in the cancellation... 2010-01-25

B Braun is threatening to reduce its investment in Malaysia. The German medical device and pharmaceutical manufacturer claims that a significant portion of its profit margin is being... 2009-06-03

Despite a challenging operating environment, the leading generic drug manufacturer in Malaysia, CCM Duopharma, has released decent financial results. This development underlines BMI's... 2009-05-27

Ithmaar Development Company is planning to expand its health island concept, the first of which is under construction in Bahrain. Three more countries - Tunisia, Morocco and Malaysia... 2008-09-23

In order to further penetrate the largest pharmaceutical market in South East Asia, Malaysian firm Pharmaniaga is planning to purchase a medium-sized Indonesian drugmaker. The move... 2008-05-27

Malaysian drugmaker Pharmaniaga wants to increase overseas sales during 2008 to build on good financial results for the year ended December 21 2007. Last year, revenue grew by 11.7%... 2008-03-17

After seeing 70% average annual growth in Malaysia during recent years, US clinical research organisation (CRO) Quintiles has identified the country as a 'key' growth market. Accordingly... 2007-12-27